Skip to main content

News & events

Jump to news

Featured event


More upcoming events

Person wearing green with pink head scarf

22 Jul 2023

Putting people first in the prevention, treatment and care of HPV-related cancers among people living with HIV

IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science.  The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting.    This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers.   People with HIV experience a substantially increased incidence of cancers associated with human papillomavirus (HPV), including cervical cancer, anal cancer, other anogenital cancers and oro-pharyngeal cancer. Globally, cervical cancer is the most common cancer in women living with HIV, and people living with HIV are more likely to develop cervical cancer at a younger age. Scale up of HPV vaccination, screening and treatment are required to meet the ambitious targets of the World Health Organization to eliminate cervical cancer as a public health problem by 2030. People living with HIV should be prioritized in this scale up.  Anal cancer is a common cancer in people living with HIV and is among the most common of all cancers in men having sex with men living with HIV. Like cervical cancer, future anal cancer cases will eventually be prevented by HPV vaccination of children. In addition, screening in people living with HIV, analogous to the cervical model, has been proposed. In 2022, a large, randomized trial reported for the first time that treatment of screen-detected pre-cancer reduced the incidence of anal cancer. Clinical societies will need to adjust to these new results and the reality that screening and treatment to prevent anal cancer is needed in people living with HIV.   The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations.   Programme and Organizing Committee  Adeeba Kamarulzaman, Universiti Malaya, Malaysia Andrew Grulich, Kirby Institute, University of NSW, Australia Joel Palefsky, University of California San Francisco, United States Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa Programme overview 09:00 – 10:00 Session 1 – Welcome and introduction: The scale of the challenges 10:10 – 10:30 Break 10:30 – 12:00 Session 2 – State-of-the-art guidance for vaccination, screen and treat 12:00 – 13:00 Lunch provided on site 13:00 – 14:30 Session 3 – Good-practice models for HPV cancer elimination 14:30 – 15:00 Break 15:00 – 16:00 Session 4 – Discussion: Current and future research gaps related to HPV cancer elimination 16:00 – 16:15 Break 16:15 – 17:00 Session 5 – Discussion: Call to action 17:00 – 18:00 Networking reception Registration To encourage the broadest participation in the pre-meeting, registration will be free. However, the meeting will be in person only and limited to 250 attendees. Stay tuned. Registration opens soon!  Please note that registration for the IAS 2023 pre-meeting: Person-centred HIV and HPV care does not grant you access to IAS 2023. Proudly supported by gold sponsor: With support from: table.table-fix { table-layout: fixed; margin-top: 32px; margin-bottom: 48px; } table.table-fix tr td { padding: 12px 16px; border-right: 2px solid #fff; } table.table-fix tr:nth-child(2n) td { background-color: #f2f5f6; }

View details View details
HIV Cure Meeting

22 Jul 2023

2023 HIV Cure & Immunotherapy Forum

The 2023 HIV Cure & Immunotherapy Forum, organized by the IAS Towards an HIV Cure initiative, will be held at the Brisbane Convention & Exhibition Centre in Brisbane, Australia, on 22 July 2023 alongside IAS 2023, the 12th IAS Conference on HIV Science. The content of the Forum will be accessible online after the meeting.   Following the success of the 2019 HIV & HBV Forum and the 2021 HIV Cure and Gene Therapy Forum, the 2023 Forum will focus on the intersection between immunotherapy and HIV cure research, building on recent advances in both fields. Its main goals are to establish a unified definition for post-intervention control, understand the biological impact of immunotherapies for cure, understand the underlying mechanisms, and learn from advances in immunotherapies in cancer therapeutics and vaccine development.  The Forum will include invited speakers, an oral abstract discussion and a panel discussion incorporating perspectives from both fields and highlighting current research directions.   Forum objectives  Accelerate research on immunotherapy curative strategies.  Create an environment to foster interdisciplinary collaborations and merge the HIV cure and immunotherapy disciplines.  Provide an opportunity for the next generation of investigators to launch their careers through interaction and discussion with peers.  Promote engagement of researchers, advocates, social and behavioural scientists, ethicists, philanthropic organizations and the private sector and seek to promote research in low- and middle-income settings.  Promote increased investments in cure research.  Provide a platform for information sharing, debate and networking among peers.  Programme Committee  Thumbi Ndung'u, Beatriz Mothe Pujadas and Anthony Kelleher will co-chair the meeting. The Forum Programme Committee will be made up of experts from both fields and include Sharon Lewin and Steve Deeks, the inaugural Co-Chairs of the IAS Towards an HIV Cure forums.  We will provide more information about the scientific programme soon. Registration To encourage the broadest participation in the forum, registration will be free. However, the meeting will be in person only and limited to 300 attendees. Stay tuned. Registration opens soon! Please note that registration for the 2023 HIV Cure & Immunotherapy Forum does not grant you access to IAS 2023.

View details View details
Munich, Germany

22 - 26 Jul 2024

The 25th International AIDS Conference

AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.

View details View details
Lima, Peru

6 - 10 Oct 2024

The 5th HIV Research for Prevention Conference

HIVR4P 2024, the 5th HIV Research for Prevention Conference will take place in Lima, Peru, and virtually from 6 to 10 October 2024 and is expected to bring together around 1,500 participants.

View details View details

Latest news